Elevated Serum KIM-1 in Sepsis Correlates with Kidney Dysfunction and the Severity of Multi-Organ Critical Illness
International Journal of Molecular Sciences · 27.05.2024 · 25 (11) · 5819
DOI: 10.3390/ijms25115819 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 27.05.2024. Verfasst von Jonathan Frederik Brozat und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department for Gastroenterology, Metabolic Disorders and Intensive Care Medicine, University Hospital RWTH Aachen, RWTH Aachen, Pauwelsstraße 30, 520…. Hauptthemen laut MEDLINE: Hepatitis A Virus Cellular Receptor 1, Sepsis, Critical Illness, Acute Kidney Injury. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Interdisciplinary Centre for Clinical Research, Faculty of Medicine RWTH Aachen, German Research Foundation.
Themen: Sepsis
Abstract (Originalsprache)
The kidney injury molecule (KIM)-1 is shed from proximal tubular cells in acute kidney injury (AKI), relaying tubular epithelial proliferation. Additionally, KIM-1 portends complex immunoregulation and is elevated after exposure to lipopolysaccharides. It thus may represent a biomarker in critical illness, sepsis, and sepsis-associated AKI (SA-AKI). To characterise and compare KIM-1 in these settings, we analysed KIM-1 serum concentrations in 192 critically ill patients admitted to the intensive care unit. Irrespective of kidney dysfunction, KIM-1 serum levels were significantly higher in patients with sepsis compared with other critical illnesses (191.6 vs. 132.2 pg/mL, p = 0.019) and were highest in patients with urogenital sepsis, followed by liver failure. Furthermore, KIM-1 levels were significantly elevated in critically ill patients who developed AKI within 48 h (273.3 vs. 125.8 pg/mL, p = 0.026) or later received renal replacement therapy (RRT) (299.7 vs. 146.3 pg/mL, p < 0.001). KIM-1 correlated with markers of renal function, inflammatory parameters, hematopoietic function, and cholangiocellular injury. Among subcomponents of the SOFA score, KIM-1 was elevated in patients with hyperbilirubinaemia (>2 mg/dL, p < 0.001) and thrombocytopenia ( 12 and APACHE II ≥ 20) on the day of admission, adjusting for relevant comorbidities, bilirubin, and platelet count. Additionally, KIM-1 in multivariate regression was able to predict sepsis in patients without prior (CKD) or present (AKI) kidney injury. Our study suggests that next to its established role as a biomarker in kidney dysfunction, KIM-1 is associated with sepsis, biliary injury, and critical illness severity. It thus may offer aid for risk stratification in these patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department for Gastroenterology, Metabolic Disorders and Intensive Care Medicine, University Hospital RWTH Aachen, RWTH Aachen, Pauwelsstraße 30, 52074 Aachen, Germany.
- Department of Hepatology and Gastroenterology, Charité-Universitätsmedizin Berlin, Campus Virchow-Klinikum (CVK) and Campus Charité Mitte (CCM), Augustenburger Platz 1, 13353 Berlin, Germany.
- Institute of Laboratory Medicine, Western Palatine Hospital, Hellmut-Hartert-Straße 1, 67655 Kaiserslautern, Germany.
- Institute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry, University Hospital Aachen, RWTH Aachen, Pauwelsstraße 30, 52074 Aachen, Germany.
ORCID-Profile: Jonathan Frederik Brozat, Philipp Hohlstein, Karim Hamesch, Eray Yagmur, Ralf Weiskirchen, Frank Tacke, Alexander Koch
Förderung
- Deutsche Forschungsgemeinschaft
- Interdisciplinary Centre for Clinical Research, Faculty of Medicine RWTH Aachen
- German Research Foundation
- Interdisciplinary Centre for Clinical Research within the Faculty of Medicine at the RWTH Aachen University
Zitieren
APA
Brozat, J. F., Harbalioğlu, N., Hohlstein, P., Abu Jhaisha, S., Pollmanns, M. R., Adams, J. K., Wirtz, T. H., Hamesch, K., Yagmur, E., Weiskirchen, R., Tacke, F., Trautwein, C., & Koch, A. (2024). Elevated Serum KIM-1 in Sepsis Correlates with Kidney Dysfunction and the Severity of Multi-Organ Critical Illness. International Journal of Molecular Sciences, 25(11), 5819. https://doi.org/10.3390/ijms25115819
Vancouver
Brozat JF, Harbalioğlu N, Hohlstein P, Abu Jhaisha S, Pollmanns MR, Adams JK, et al. Elevated Serum KIM-1 in Sepsis Correlates with Kidney Dysfunction and the Severity of Multi-Organ Critical Illness. International Journal of Molecular Sciences. 2024;25(11):5819. doi:10.3390/ijms25115819
BibTeX
@article{Brozat2024,
author = {Brozat, Jonathan Frederik and Harbalioğlu, Neval and Hohlstein, Philipp and Abu Jhaisha, Samira and Pollmanns, Maike Rebecca and Adams, Jule Katharina and Wirtz, Theresa Hildegard and Hamesch, Karim and Yagmur, Eray and Weiskirchen, Ralf and Tacke, Frank and Trautwein, Christian and Koch, Alexander},
title = {Elevated Serum KIM-1 in Sepsis Correlates with Kidney Dysfunction and the Severity of Multi-Organ Critical Illness},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {11},
pages = {5819},
doi = {10.3390/ijms25115819}
}
EUVIMED